Procainamide therapy when compared with IV amiodarone for the treatment of acute sustained monomorphic wide QRS tachycardia was associated with less major cardiac adverse events (MACE) and a higher proportion of tachycardia termination within 40 minutes.
PROCAMIO Trial
PART trial
FALLS protocol
ACS - Risk Stratification
STOPP/START criteria
Unstable Angina - NSTEMI Guidelines
Denver screening criteria
Recommendation Grading System